Aceso Life Science Group Unit to Raise HK$600 Million via Share Placement

MT Newswires Live10-28

Aceso Life Science Group's (HKG:0474) subsidiary Hao Tian International Construction Investment Group (HKG:1341) is looking to raise up to HK$600 million in net proceeds via placement of up to 1,524,224,000 shares at HK$0.4 per share.

The number of shares to be placed represents 16.67% of the enlarged issued share capital of Hao Tian International, a Friday Hong Kong bourse filing said.

If all the shares are successfully placed, the company's shareholding in Hao Tian International will be diluted from 29.05% to 24.20% and Hao Tian International will cease to be a subsidiary of the company.

Hao Tian International plans to use the proceeds for its general working capital, development of its existing businesses, and for the investment and development of electric vehicles and charging station-related businesses.

The financial, property, and construction machinery company's shares closed nearly 3% lower on Monday.

Price (HKD): $0.08, Change: $-0.0020, Percent Change: -2.50%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment